Heart Failure Reviews

Article	Citations
Heart failure and COVID-19	139
Biomarkers for the diagnosis and management of heart failure	128
COVID-19 and myocarditis: a systematic review and overview of current challenges	115
Machine learning versus conventional clinical methods in guiding management of heart failure patients—a systematic review	54
Anthracycline-induced cardiotoxicity: mechanisms of action, incidence, risk factors, prevention, and treatment	53
Mechanisms of COVID-19-induced heart failure: a short review	44
Extracellular matrix–based biomaterials for cardiac regeneration and repair	44
Dilated cardiomyopathy in the era of precision medicine: latest concepts and developments	41
Pathogenesis of chronic heart failure: cardiovascular aging, risk factors, comorbidities, and disease modifiers	40
Polypharmacy definition and prevalence in heart failure: a systematic review	40
Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets	40
SGLT2-inhibitors; more than just glycosuria and diuresis	39
The prognostic role of speckle tracking echocardiography in clinical practice: evidence and reference values from the literature	38
Clinical inertia in the treatment of heart failure: a major issue to tackle	38
Anthracycline-induced cardiotoxicity and renin-angiotensin-aldosterone system—from molecular mechanisms to therapeutic applications	36
Nutritional interventions for heart failure patients who are malnourished or at risk of malnutrition or cachexia: a systematic review and meta-analysis	35
The transverse aortic constriction heart failure animal model: a systematic review and meta-analysis	34
Non-ischemic dilated cardiomyopathy and cardiac fibrosis	34
Therapeutic angiogenesis with exosomal microRNAs: an effectual approach for the treatment of myocardial ischemia	33
The Elabela-APJ axis: a promising therapeutic target for heart failure	33
The role and molecular mechanism of epigenetics in cardiac hypertrophy	30
The role of non-invasive devices for the telemonitoring of heart failure patients	29
Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness	27
Mitochondrial abnormalities: a hub in metabolic syndrome-related cardiac dysfunction caused by oxidative stress	26
Transthyretin amyloid cardiomyopathy in women: frequency, characteristics, and diagnostic challenges	25

Resistance training in heart failure patients: a systematic review and meta-analysis	25
Detection of myocardial fibrosis by speckle-tracking echocardiography: from prediction to clinical applications	24
Distinctive patterns of inflammation across the heart failure syndrome	24
A meta-analysis of microRNA expression profiling studies in heart failure	24
Renal protection: a leading mechanism for cardiovascular benefit in patients treated with SGLT2 inhibitors	23
Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for cardiovascular outcomes in type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials	22
The utility of growth differentiation factor-15, galectin-3, and sST2 as biomarkers for the diagnosis of heart failure with preserved ejection fraction and compared to heart failure with reduced eject	22
Mechanisms underlying the pathophysiology of heart failure with preserved ejection fraction: the tip of the iceberg	22
Current and emerging drug targets in heart failure treatment	21
Cardiogenic shock and acute kidney injury: the rule rather than the exception	21
The non-invasive assessment of myocardial work by pressure-strain analysis: clinical applications	21
Multiple roles of cardiac macrophages in heart homeostasis and failure	21
Myocarditis following COVID-19 vaccination in adolescents and adults: a cumulative experience of 2021	20
Immunity and inflammation: the neglected key players in congenital heart disease?	20
Effect of beta-blockers on heart failure severity in patients with heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials	20
Cardiorenal syndrome: long road between kidney and heart	19
Angiotensin-converting enzyme 2: a double-edged sword in COVID-19 patients with an increased risk of heart failure	19
Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases	18
The roles of epicardial adipose tissue in heart failure	18
Left ventricular hypertrophy and sudden cardiac death	18
SGLT2 inhibitors: a focus on cardiac benefits and potential mechanisms	18
Palliative care needs-assessment and measurement tools used in patients with heart failure: a systematic mixed-studies review with narrative synthesis	18
SGLT2 inhibitors break the vicious circle between heart failure and insulin resistance: targeting energy metabolism	18
Ventricular non-compaction review	18
Metformin and heart failure–related outcomes in patients with or without diabetes: a systematic review of randomized controlled trials	18
Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide	18
Effect of exercise on epicardial adipose tissue in adults: a systematic review and meta-analyses	18
Management of RAASi-associated hyperkalemia in patients with cardiovascular disease	17
Prognostic value of natriuretic peptides in heart failure: systematic review and meta-analysis	17
Filamin C in cardiomyopathy: from physiological roles to DNA variants	17
Right ventricular involvement in cancer therapy–related cardiotoxicity: the emerging role of strain echocardiography	17
Pirfenidone as a novel cardiac protective treatment	17
Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis	16
Device-based treatment options for heart failure with preserved ejection fraction	16
The use of diflunisal for transthyretin cardiac amyloidosis: a review	16
Sodium glucose cotransporter 2 inhibitors: mechanisms of action in heart failure	16
Diagnosis and management of the adult patient with a failing Fontan circulation	16
Heart–lung interactions in COVID-19: prognostic impact and usefulness of bedside echocardiography for monitoring of the right ventricle involvement	16
SGLT2 inhibitors and cardiovascular and renal outcomes: a meta-analysis and trial sequential analysis	16
Heart failure and atrial fibrillation: new concepts in pathophysiology, management, and future directions	16
Hospitalisation costs associated with heart failure with preserved ejection fraction (HFpEF): a systematic review	15
The protective effects of 17-β estradiol and SIRT1 against cardiac hypertrophy: a review	15
Machine learning and statistical methods for predicting mortality in heart failure	15
Therapeutic augmentation of NO-sGC-cGMP signalling: lessons learned from pulmonary arterial hypertension and heart failure	15
Cardiac xenotransplantation: a promising way to treat advanced heart failure	15
Lung ultrasound–guided management to reduce hospitalization in chronic heart failure: a systematic review and meta-analysis	15
Cardiac complications in inherited mitochondrial diseases	14
The role of cardiac magnetic resonance imaging in the detection and monitoring of cardiotoxicity in patients with breast cancer after treatment: a comprehensive review	14
Remote monitoring for heart failure using implantable devices: a systematic review, meta-analysis, and meta-regression of randomized controlled trials	14
Right ventricular phenotype, function, and failure: a journey from evolution to clinics	13

Efficacy of motivational interviewing on enhancing self-care behaviors among patients with chronic heart failure: a systematic review and meta-analysis of randomized controlled trials	13
Transplant and mechanical circulatory support in patients with adult congenital heart disease	13
Diagnostic value of echocardiographic markers for diastolic dysfunction and heart failure with preserved ejection fraction	13
Effects of catheter-based renal denervation on heart failure with reduced ejection fraction: a meta-analysis of randomized controlled trials	13
Creatine deficiency and heart failure	13
Balloon pulmonary angioplasty vs. pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis	12
Association of loop diuretics use and dose with outcomes in outpatients with heart failure: a systematic review and meta-analysis of observational studies involving 96,959 patients	12
Cardiovascular magnetic resonance for the diagnosis and management of heart failure with preserved ejection fraction	12
Peripartum cardiomyopathy: a review	12
Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction	12
Prognostic significance of T1 mapping parameters in heart failure with preserved ejection fraction: a systematic review	12
Epidemiology and clinical manifestations of cardiac amyloidosis	12
The management of atrial fibrillation in heart failure: an expert panel consensus	12
New antidiabetic therapy and HFpEF: light at the end of tunnel?	12
Left atrial structure and function in heart failure with reduced (HFrEF) versus preserved ejection fraction (HFpEF): systematic review and meta-analysis	11
Ultrafiltration is better than diuretic therapy for volume-overloaded acute heart failure patients: a meta-analysis	11
Beneficial effects on kidney during treatment with sodium-glucose cotransporter 2 inhibitors: proposed role of ketone utilization	11
Cardiac imaging in cardiotoxicity: a focus on clinical practice	11
The heart and gut relationship: a systematic review of the evaluation of the microbiome and trimethylamine-N-oxide (TMAO) in heart failure	11
Cost-effectiveness analyses of sacubitril-valsartan for heart failure	11
Dilated cardiomyopathy: a new insight into the rare but common cause of heart failure	11
Effects of bromocriptine in peripartum cardiomyopathy: a systematic review and meta-analysis	11
Cor pulmonale: the role of traditional and advanced echocardiography in the acute and chronic settings	10
Comparative effects of furosemide and other diuretics in the treatment of heart failure: a systematic review and combined meta-analysis of randomized controlled trials	10
Comprehensive assessment of hypertensive heart disease: cardiac magnetic resonance in focus	10
Definition of left ventricular remodelling following ST-elevation myocardial infarction: a systematic review of cardiac magnetic resonance studies in the past decade	10
Hormonal prostate cancer therapies and cardiovascular disease: a systematic review	10
Cardiac contractility modulation for the treatment of heart failure with reduced ejection fraction	10
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis	10
Crosstalk between GSK-3β-actuated molecular cascades and myocardial physiology	10
Targeting mitochondrial dysfunction with elamipretide	9
Vitamin C: historical perspectives and heart failure	9
A critical approach for successful use of circulating microRNAs as biomarkers in cardiovascular diseases: the case of hypertrophic cardiomyopathy	9
A systematic review exploring the significance of measuring epicardial fat thickness in correlation to B-type natriuretic peptide levels as prognostic and diagnostic markers in patients with or at ris	9
The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction	9
Diabetes-related cardiovascular and economic burden in patients hospitalized for heart failure in the US: a recent temporal trend analysis from the National Inpatient Sample	9
Subclinical cardiac damage in cancer patients before chemotherapy	9
Fibrosis in hypertrophic cardiomyopathy: role of novel echo techniques and multi-modality imaging assessment	9
Cardiac contractility modulation for patient with refractory heart failure: an updated evidence-based review	9
Serum potassium and heart failure: association, causation, and clinical implications	9
The genetics of cardiac amyloidosis	9
The soluble catalytic ectodomain of ACE2 a biomarker of cardiac remodelling: new insights for heart failure and COVID19	9
Diagnostic algorithm for HFpEF: how much is the recent consensus applicable in clinical practice?	9
Patients with fulminant myocarditis supported with veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis of short-term mortality and impact of risk factors	8
Impact of atrial fibrillation on the outcomes of transcatheter mitral valve repair using MitraClip: a systematic review and meta-analysis	8
Physical activity and exercise training in heart failure with preserved ejection fraction: gathering evidence from clinical and pre-clinical studies	8
Paradigm shift in heart failure treatment: are cardiologists ready to use gliflozins?	8
Speckle tracking echocardiography in primary mitral regurgitation: should we reconsider the time for intervention?	8
Cardiotoxicity in HER2-positive breast cancer patients	8
Research progress of biomarkers in early detection of chemotherapy-induced cardiotoxicity	8
Left atrial assist device for heart failure with preserved ejection fraction: initial results with torque control mode in diastolic heart failure model	8
Cognitive impairment in heart failure: clinical implications, tools of assessment, and therapeutic considerations	8
Psychological stress in heart failure: a potentially actionable disease modifier	8
Prognostic impact of antiplatelet therapy in Takotsubo syndrome: a systematic review and meta-analysis of the literature	8
Complications in children with ventricular assist devices: systematic review and meta-analyses	8
Targeting the forkhead box protein P1 pathway as a novel therapeutic approach for cardiovascular diseases	8
Cardiac resynchronization therapy in heart failure patients: tough road but clear future	8
The therapeutic effects of upgrade to cardiac resynchronization therapy in pacing-induced cardiomyopathy or chronic right ventricular pacing patients: a meta-analysis	8
MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkers	8
Vaccines against components of the renin–angiotensin system	8
Arrhythmic risk stratification by cardiac magnetic resonance tissue characterization: disclosing the arrhythmic substrate within the heart muscle	8
Optimal effectiveness of heart failure management — an umbrella review of meta-analyses examining the effectiveness of interventions to reduce (re)hospitalizations in heart failure	8
Is heart failure with preserved ejection fraction a ‘dementia’ of the heart?	8
Large animal models of heart failure with preserved ejection fraction	8
Weighing in on heart failure: the potential impact of bariatric surgery	8
Mechanistic implications of altered protein expression in rheumatic heart disease	7
Cardiovascular disease associated with methamphetamine use: a review	7
Cardiogenic shock in autoimmune rheumatologic diseases: an insight on etiologies, management, and treatment outcomes	7
The cardiosplenic axis: the prognostic role of the spleen in heart failure	7
Heart failure in the adult Ebstein patient	7
Global longitudinal strain predicts responders after cardiac resynchronization therapy—a systematic review and meta-analysis	7
Soluble ST2: a valuable prognostic marker in heart failure	7
Assessment of acute heart failure prognosis: the promising role of prognostic models and biomarkers	7
Ventricular arrhythmias and ARNI: is it time to reappraise their management in the light of new evidence?	7
Beyond genomics—technological advances improving the molecular characterization and precision treatment of heart failure	7
Speckle tracking echocardiography in heart failure development and progression in patients with apneas	7
A systematic review on focal takotsubo syndrome: a not-so-small matter	7
Angiotensin receptor-neprilysin inhibition in patients with acute decompensated heart failure: an expert consensus position paper	7
Clinical variants of myocardial involvement in COVID-19-positive patients: a cumulative experience of 2020	7
State-of-the art review: Noncompaction cardiomyopathy in pediatric patients	7

Etiology and pathophysiology of heart failure in people with HIV	7
Treatment of cardiac fibrosis: from neuro-hormonal inhibitors to CAR-T cell therapy	7
The role of lymphangiogenesis in cardiovascular diseases and heart transplantation	7
ST-elevation myocardial infarction among cardiac amyloidosis patients; a national readmission database study	7
Peripartum cardiomyopathy	7